Impact of Exenatide on Sleep Duration and Quality in Type 2 Diabetes

Trial Profile

Impact of Exenatide on Sleep Duration and Quality in Type 2 Diabetes

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Exenatide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Sep 2016 Planned End Date changed from 1 Jul 2016 to 1 Dec 2016.
    • 01 Sep 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Dec 2016.
    • 25 Jul 2016 Planned End Date changed from 1 Dec 2013 to 1 Jul 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top